Treatment of Clinically Non-Functioning Pituitary Adenoma: Macroadenoma with Visual Field Risk

Clinically non-functioning pituitary adenomas (NFPAs) do not produce a recognised hormonal excess syndrome. When the tumour reaches macroadenoma size, it can compress adjacent optic structures and threaten visual function — a finding that drives the timing and nature of the management decision.

Clinical Situation

This protocol applies to the macroadenoma presentation of a clinically non-functioning pituitary adenoma — where tumour size brings visual pathways into the picture. Careful surveillance of visual function is central to determining when and how to act.

Treatment Approach

A surgical approach is the primary intervention considered for this macroadenoma scenario. The full protocol — including patient selection, operative details, and post-operative management — is available via the link below.

Treatment Goals

The principal clinical objective is normalization or meaningful improvement of visual fields following intervention. Individual outcomes vary, and monitoring continues after treatment.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/ejendo/lvaf091

View source ↗